Sucrose fatty acid esters suppress pancreatic secretion accompanied by peptide YY release in pancreatico-biliary diverted rats.
Our previous study demonstrated that intestinal administration of triglycerides suppressed protein-induced increases in pancreatic exocrine secretion in pancreatico-biliary diverted (PBD) rats, though the mechanism has not been clarified. The present study was conducted to determine whether esterified fatty acids or free fatty acids are responsible for this suppression, and whether an esterified fatty acid stimulates secretion of a pancreatic inhibitory hormone, peptide YY (PYY). We examined the effects of cocoa butter or non-digestible sucrose fatty acid esters on protein-induced pancreatic secretion in conscious PBD rats whose bile-pancreatic juice was diverted from the proximal small intestine through a catheter. Intraduodenal administration of the protein guanidinated casein hydrolysate (HGC, 150 mg in 1 ml water) enhanced pancreatic protein and trypsin secretion. However, administration of HGC with cocoa butter (100 mg ml(-1)) partly suppressed the increase in pancreatic secretion, and HGC with a highly esterified sucrose fatty acid ester, F-10 (100 mg ml(-1)), completely suppressed it. The low-esterified, water-soluble sucrose fatty acid ester F-160 also completely inhibited protein-induced pancreatic secretion in the presence or absence of the lipase inhibitor orlistat. In anaesthetized PBD rats, intraduodenal administration of HGC with sucrose ester F-160 suppressed HGC-induced pancreatic secretion, and induced PYY secretion more strongly than HGC with sucrose. These results suggest that the esterified fatty acid itself stimulates PYY release in the distal intestine, thereby inhibiting protein-induced pancreatic secretion.
Hira
Tohru
T
Division of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kita-ku, Sapporo 060-8589, Japan. hira@chem.agr.hokudai.ac.jp
Takahashi
Katsuhiko
K
Hara
Hiroshi
H
D000818:Animals; D001646:Bile / Q000502:physiology*; D001658:Biliary Fistula; D002364:Caseins / Q000494:pharmacology; D004041:Dietary Fats / Q000494:pharmacology; D004952:Esters / Q000494:pharmacology; D019791:Guanidine / Q000494:pharmacology; D007082:Ileum / Q000502:physiology; D008297:Male; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism*; D010185:Pancreatic Fistula; D010189:Pancreatic Juice / Q000502:physiology*; D019894:Peptide YY / Q000378:metabolism*; D051381:Rats; D013395:Sucrose / Q000031:analogs & derivatives* / Q000494:pharmacology; D014357:Trypsin / Q000378:metabolism
D002364:Caseins; D004041:Dietary Fats; D004952:Esters; D019894:Peptide YY; C018153:sucrose monostearate; C052387:cocoa butter; D013395:Sucrose; C475729:casein hydrolysate; D014357:Trypsin; D019791:Guanidine